Ceramide inhibits IL-2 production by preventing protein kinase C-dependent NF-κB activation: Possible role in protein kinase Cθ regulation

Journal of Immunology

Volumn 173, Issue 5, 2004, Pages 3193-3200

  Abbonshi, Nour ^a   El Hed, Aimee ^a   El Assaad, Wissal ^a   Kozhaya, Lina ^a   El Sabban, Marwan E ^a   Bazarbachi, Ali ^a   Badreddine, Rami ^a   Bielawska, Alicja ^b   Usta, Julnar ^a   Dbaibo, Ghassan S ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; GLYCOSPHINGOLIPID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; ENZYME INHIBITION; ENZYME REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; LEUKEMIA CELL LINE; PRIORITY JOURNAL;

EID: 4344710126     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.5.3193     Document Type: Article

References (43)

1. Hannun, Y. A., and L. M. Obeid. 2002. The ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. J. Biol. Chem. 277:25847.
2. Ladisch, S. 1996. Biological significance of tumor gangliosides: shedding, transfer, and immunosuppression. In Frontiers of Bioactive Lipids. J. Y. Vanderhoek, ed. Plenum Press, New York, p. 215.
3. Irani, D. N., K. I. Lin, and D. E. Griffin. 1996. Brain-derived gangliosides regulate the cytokine production and proliferation of activated T cells. J. Immunol. 157:4333.
4. Shurin, G. V., M. R. Shurin, S. Bykovskaia, J. Shogan, M. T. Lotze, and E. M. Barksdale, Jr. 2001. Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function. Cancer Res. 61:363.
5. Persat, F., C. Vincent, D. Schmitt, and M. Mojon. 1996. Inhibition of human peripheral blood mononuclear cell proliferative response by glycosphingolipids from metacestodes of Echinococcus multilocularis. Infect. Immun. 64:3682.
6. Gomes, N. A., J. O. Previato, B. Zingales, L. Menonça-Previato, and G. A. DosReis. 1996. Down-regulation of T lymphocyte activation in vitro and in vivo induced by glycoinositolphospholipids from Trypanosoma cruzi: assignment of the T cell-suppressive determinant to the ceramide domain. J. Immunol. 156:628.
7. Mathias, S., A. Younes, C.-C. Kan, I. Orlow, C. Joseph, and R. N. Kolesnick. 1993. Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1β. Science 259:519.
8. Schütze, S., K. Potthoff, T. Machleidt, D. Berkovic, K. Wiegmann, and M. Krönke. 1992. TNF activates NF-κB by phosphatidylcholine- specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 71:765.
9. Yang, Z., M. Costanzo, D. W. Golde, and R. N. Kolesnick. 1993. Tumor necrosis factor activation of the sphingomyelin pathway signals nuclear factor κB translocation in intact HL-60 cells. J. Biol. Chem. 268:20520.
10. 2, but not that activated by ceramide, lipopolysaccharides, or phorbol ester. J. Immunol. 168:2644.
11. Dbaibo, G. S., L. M. Obeid, and Y. A. Hannun. 1993. TNFα signal transduction through ceramide: dissociation of growth inhibitory effects of TNFα from activation of NF-κB. J. Biol. Chem. 268:17762.
12. Betts, J. C., A. B. Agranoff, G. J. Nabel, and J. A. Shayman. 1994. Dissociation of endogenous cellular ceramide from NF-KB activation. J. Biol. Chem. 269:8455.
13. Andrieu, N., R. Salvayre, and T. Levade. 1994. Evidence against involvement of the acid lysosomal sphingomyelinase in the tumor-necrosis-factor- and interleukin-1-induced sphingomyelin cycle and cell proliferation in human fibroblasts. Biochem. J. 303:341.
14. Signorelli, P., C. Luberto, and Y. A. Hannun. 2001. Ceramide inhibition of NF-κB activation involves reverse translocation of classical protein kinase C (PKC) isoenzymes: requirement for kinase activity and carboxyl-terminal phosphorylation of PKC for the ceramide response. FASEB J. 15:2401.
15. Baldwin, A. S., Jr. 1996. The NF-κB and I κB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649.
16. Jain, J., C. Loh, and A. Rao. 1995. Transcriptional regulation of the IL-2 gene. Curr. Opin. Immunol. 7:333.
17. Rothenberg, E., and S. Ward. 1996. A dynamic assembly of diverse transcription factors integrates activation and cell-type information for interleukin 2 gene regulation. Proc. Natl. Acad. Sci. USA 93:9358.
18. Bielawska, A., H. M. Crane, D. Liotta, L. M. Obeid, and Y. A. Hannun. 1993. Selectivity of ceramide-mediated biology: lack of activity of erythro-dihydroceramide. J. Biol. Chem. 268:26226.
19. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911.
20. Dbaibo, G. S., D. K. Perry, C. J. Gamard, R. Platt, G. G. Poirier, L. M. Obeid, and Y. A. Hannun. 1997. Cytokine response modifier A (CrmA) inhibits ceramide formation in response to tumor necrosis factor (TNF)α: CrmA and Bcl-2 target distinct components in the apoptotic pathway. J. Exp. Med. 185:481.
21. Merrill, A. H., Jr., E. Wang, R. E. Mullins, W. C. L. Jamison, S. Nimkar, and D. C. Liotta. 1988. Quantitation of free sphingosine by high performance liquid chromatography. Anal. Biochem. 171:373.
22. Gamard, C. J., G. S. Dbaibo, B. Liu, L. M. Obeid, and Y. A. Hannun. 1997. Selective involvement of ceramide in cytokine-induced apoptosis: ceramide inhibits phorbol ester activation of nuclear factor κB. J. Biol. Chem. 272:16474.
23. Isakov, N., and A. Altman. 2002. Protein kinase Cθ in T cell activation. Annu. Rev. Immunol. 20:761.
24. Sun, Z., C. Arendt, W. Ellmeier, E. Schaeffer, M. Sunshine, L. Gandhi, J. Annes, D. Petrzilka, A. Kupfer, P. Schwartzberg, et al. 2000. PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes. Nature 404:402.
25. Lozano, J., E. Berra, M. M. Municio, M. T. Diaz-Meco, I. Dominguez, L. Sanz, and J. Moscat. 1994. Protein kinase C ζ isoform is critical for κB-dependent promoter activation by sphingomyelinase. J. Biol. Chem. 269:19200.
26. Lee, J. Y., Y. A. Hannun, and L. M. Obeid. 1996. Ceramide inactivates cellular protein kinase Cα. J. Biol. Chem. 271:13169.
27. Sawai, H., T. Okazaki, Y. Takeda, M. Tashima, H. Sawada, M. Okuma, S. Kishi, H. Umehara, and N. Domae. 1997. Ceramide-induced translocation of protein kinase C-δ and -ε to the cytosol: implications in apoptosis. J. Biol. Chem. 272:2452.
28. Bourbon, N., J. Yun, D. Berkey, Y. Wang, and M. Kester. 2001. Inhibitory actions of ceramide upon PKC-ε/ERK interactions. Am. J. Physiol. 280:C1403.
29. Lee, J., Y. Hannun, and L. Obeid. 2000. Functional dichotomy of protein kinase C in TNFα signal transduction in L929 cells. J. Biol. Chem. 275:29290.
30. Chalfant, C. E., B. Ogretmen, S. H. Galadari, B.-J. Kroesen, B. J. Pettus, and Y. A. Hannun. 2001. FAS activation induces dephosphorylation of SR proteins: dependence on the de novo generation of ceramide and activation of protein phosphatase-1. J. Biol. Chem. 276:44848.
31. Linardic, C. M., S. Jayadev, and Y. A. Hannun. 1996. Activation of the sphingomyelin cycle by brefeldin A: effects of brefeldin A on differentiation and implications for a role for ceramide in regulation of protein trafficking. Cell Growth Differ. 7:765.
32. Koike, T., H. Yamagishi, Y. Hatanaka, A. Fukushima, J. W. Chang, Y. Xia, M. Fields, P. Chandler, and M. Iwashima. 2003. A novel ERK-dependent signaling process that regulates interleukin-2 expression in a late phase of T cell activation. J. Biol. Chem. 278:15685.
33. Coroneos, E., Y. Wang, J. R. Panuska, D. J. Templeton, and M. Kester. 1996 Sphingolipid metabolites differentially regulate extracellular signal-regulated kinase and stress-activated protein kinase cascades. Biochem. J. 316:13.
34. Meichle, A., S. Schütze, G. Hensel, D. Brunsing, and M. Krönke. 1990. Protein kinase C-independent activation of nuclear factor κB by tumor necrosis factor. J. Biol. Chem. 265:8339.
35. 2+-regulated kinases. Cytokine 3:257.
36. Radin, N. S., J. A. Shayman, and J.-I. Inokuchi. 1993. Metabolic effects of inhibiting glucosylceramide synthesis with PDMP and other substances. Adv. Lipid Res. 26:183.
37. Hannun, Y. A., C. R. Loomis, A. H. Merrill, Jr., and R. M. Bell. 1986. Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and human platelets. J. Biol. Chem. 261:12604.
38. Pahlavani, M., and D. Vargas. 2000. The effect of a ceramide analog, N-acetyl-sphingosine on the induction of proliferation and IL-2 synthesis in T cells from young and old F344 rats. Immunopharmacology 49:345.
39. Szamel, M., A. Appel, R. Schwinzer, and K. Resch. 1998. Different protein kinase C isoenzymes regulate IL-2 receptor expression or IL-2 synthesis in human lymphocytes stimulated via the TCR. J. Immunol. 160:2207.
40. Monks, C., H. Kupfer, I. Tamir, A. Barlow, and A. Kupfer. 1997. Selective modulation of protein kinase C-θ during T-cell activation. Nature 385:83.
41. Werlen, G., E. Jacinto, Y. Xia, and M. Karin. 1998. Calcineurin preferentially synergizes with PKC-θ to activate JNK and IL-2 promoter in T lymphocytes. EMBO J. 17:3101.
42. Trushin, S., K. Pennington, A. Algeciras-Schimnich, and C. Paya. 1999. Protein kinase C and calcineurin synergize to activate IκB kinase and NF-κB in T lymphocytes. J. Biol. Chem. 274:22923.
43. Persat, F., J. F. Bouhours, A. F. Petavy, and M. Mojon. 1995. Free ceramides of Echinococcus multilocularis metacestodes. Biochim. Biophys. Acta 1255:280.